Processa Pharmaceuticals (PCSA) Short Interest Ratio & Short Volume $0.85 -0.09 (-9.84%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals Short Interest DataProcessa Pharmaceuticals (PCSA) has a short interest of 71,600 shares, representing 2.47% of the float (the number of shares available for trading by the public). This marks a -2.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.12 million shares to cover all short positions.Current Short Interest71,600 sharesPrevious Short Interest73,100 sharesChange Vs. Previous Month-2.05%Dollar Volume Sold Short$82,769.60Short Interest Ratio0.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares3,267,000 sharesFloat Size2,900,000 sharesShort Percent of Float2.47%Today's Trading Volume191,585 sharesAverage Trading Volume1,117,567 sharesToday's Volume Vs. Average17% Short Selling Processa Pharmaceuticals? Sign up to receive the latest short interest report for Processa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCSA Short Interest Over TimePCSA Days to Cover Over TimePCSA Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Processa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202471,600 shares $82,769.60 -2.1%2.5%0.2 $1.16 11/15/202473,100 shares $73,823.69 -25.0%2.5%1.1 $1.01 10/31/202497,400 shares $112,497.00 -40.5%3.4%1.3 $1.16 10/15/2024163,600 shares $202,864.00 +164.3%5.7%0.2 $1.24 9/30/202461,900 shares $84,803.00 -16.1%2.1%0.1 $1.37 9/15/202473,800 shares $98,892.00 -24.2%2.6%0.1 $1.34 Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202497,300 shares $134,274.00 -7.2%3.4%0.1 $1.38 8/15/2024104,800 shares $137,288.00 -88.9%3.7%0.1 $1.31 7/31/2024942,300 shares $1.98 million +1,834.9%38.0%0.9 $2.10 7/15/202448,700 shares $84,738.00 -28.8%1.9%0 $1.74 6/30/202468,400 shares $153,216.00 -51.9%2.7%0.1 $2.24 6/15/2024142,200 shares $248,850.00 +532.0%5.7%0.1 $1.75 5/31/202422,500 shares $33,300.00 -52.6%0.9%0 $1.48 5/15/202447,500 shares $95,950.00 -91.6%1.9%0 $2.02 4/30/2024568,300 shares $1.24 million +199.7%24.8%0.4 $2.18 4/15/2024189,600 shares $287,244.00 +429.6%8.3%0.1 $1.52 3/31/202435,800 shares $84,667.00 -11.2%1.6%0 $2.37 3/15/202440,300 shares $88,257.00 -40.1%2.9%0 $2.19 2/29/202467,300 shares $165,558.00 -29.7%5.4%0 $2.46 2/15/202495,700 shares $232,551.00 -41.0%7.7%0.1 $2.43 1/31/2024162,100 shares $382,556.00 +1,721.4%12.5%0.1 $2.36 1/15/20248,900 shares $46,796.20 -98.0%0.7%0.1 $5.26 12/31/2023443,300 shares $148,328.18 +46.3%N/A0.2 $0.33 12/15/2023303,000 shares $216,645.00 -17.6%N/A0.1 $0.72 11/30/2023367,800 shares $235,392.00 +55.1%N/A0.2 $0.64 11/15/2023237,200 shares $93,456.80 +13.6%N/A0.1 $0.39 10/31/2023208,900 shares $73,323.90 +13.0%N/A0.1 $0.35 10/15/2023184,800 shares $88,704.00 +43.4%N/A0.1 $0.48 9/30/2023128,900 shares $32,250.78 -6.7%N/A1.2 $0.25 9/15/2023138,100 shares $53,168.50 +14.9%N/A1.8 $0.39 8/31/2023120,200 shares $37,742.80 +31.8%N/A1 $0.31 8/15/202391,200 shares $34,656.00 +11.6%N/A0.8 $0.38 7/31/202381,700 shares $35,948.00 -6.6%N/A0.7 $0.44 7/15/202387,500 shares $40,512.50 -28.7%N/A0.7 $0.46 6/30/2023122,700 shares $61,043.25 -32.6%N/A1 $0.50 6/15/2023182,000 shares $109,200.00 -9.6%N/A1.6 $0.60 5/31/2023201,300 shares $124,806.00 +3.2%N/A2.3 $0.62 5/15/2023195,000 shares $128,505.00 +0.5%N/A2.1 $0.66 4/30/2023194,000 shares $122,220.00 +18.7%N/A1.6 $0.63 4/15/2023163,500 shares $81,750.00 -12.3%N/A0.6 $0.50⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 3/31/2023186,400 shares $93,218.64 -41.7%N/A0.7 $0.50 3/15/2023319,700 shares $164,325.80 -14.3%N/A1.2 $0.51 2/28/2023372,900 shares $249,805.71 -15.8%N/A1.4 $0.67 2/15/2023442,800 shares $352,026.00 +94.5%N/A1.7 $0.80 1/31/2023227,700 shares $194,683.50 -1.6%2.0%0.9 $0.86 1/15/2023231,500 shares $289,375.00 -9.3%2.0%5.2 $1.25 12/30/2022255,300 shares $280,830.00 +124.7%2.2%6.3 $1.10 12/15/2022113,600 shares $214,704.00 +38.4%1.0%3 $1.89 11/30/202282,100 shares $155,948.95 +11.7%0.7%4.3 $1.90 11/15/202273,500 shares $151,410.00 -5.3%0.7%4.3 $2.06 10/31/202277,600 shares $164,512.00 +7.0%0.7%5.5 $2.12 10/15/202272,500 shares $160,950.00 -13.3%0.7%5.6 $2.22 9/30/202283,600 shares $188,936.00 +27.3%0.8%6.6 $2.26 9/15/202265,700 shares $170,820.00 +0.2%0.6%4.6 $2.60 8/31/202265,600 shares $180,400.00 -4.8%0.6%4.5 $2.75 8/15/202268,900 shares $224,614.00 -4.8%0.6%4.3 $3.26 7/31/202272,400 shares $224,440.00 -17.6%0.6%2.9 $3.10 7/15/202287,900 shares $296,776.77 -15.3%0.8%3.2 $3.38 6/30/2022103,800 shares $291,678.00 -5.3%0.9%3.3 $2.81 6/15/2022109,600 shares $283,864.00 -11.3%0.9%3.6 $2.59 5/31/2022123,500 shares $314,925.00 +31.9%1.1%3.6 $2.55 5/15/202293,600 shares $169,416.00 +19.7%0.8%2.8 $1.81 4/30/202278,200 shares $216,614.00 +8.0%0.7%2.6 $2.77 4/15/202272,400 shares $230,956.00 -9.1%0.6%2.2 $3.19 3/31/202279,600 shares $239,596.00 -21.2%0.7%2.5 $3.01 3/15/2022101,000 shares $349,460.00 +8.6%0.9%3 $3.46 2/28/202293,000 shares $356,190.00 -18.6%0.8%2.6 $3.83 2/15/2022114,300 shares $417,195.00 -5.4%1.0%2.9 $3.65 1/31/2022120,800 shares $446,960.00 +5.1%3.0%2.8 $3.70 1/15/2022114,900 shares $499,815.00 +18.5%2.8%2.6 $4.35 12/31/202197,000 shares $475,300.00 +11.9%2.4%2.2 $4.90 12/15/202186,700 shares $362,406.00 +7.4%2.1%1.7 $4.18 11/30/202180,700 shares $440,622.00 -11.8%2.0%1.5 $5.46 11/15/202191,500 shares $589,260.00 -2.5%2.3%1.5 $6.44 10/29/202193,800 shares $649,096.00 -16.4%2.3%1.6 $6.92 10/15/2021112,200 shares $879,648.00 +4.7%2.8%1.1 $7.84 9/30/2021107,200 shares $918,704.00 +15.4%2.6%1.1 $8.57 9/15/202192,900 shares $690,247.00 +17.6%2.3%1 $7.43 8/31/202179,000 shares $515,080.00 -4.9%2.2%0.8 $6.52 8/13/202183,100 shares $449,571.00 -28.7%2.3%0.9 $5.41 7/30/2021116,500 shares $696,670.00 -8.6%3.3%1.3 $5.98 7/15/2021127,500 shares $860,625.00 -7.9%3.6%2.6 $6.75 6/30/2021138,400 shares $1.13 million +107.8%3.9%2.6 $8.19 6/15/202166,600 shares $442,890.00 +8.1%1.9%0.9 $6.65 5/28/202161,600 shares $378,840.00 -8.1%1.7%0.9 $6.15 5/14/202167,000 shares $412,720.00 -8.7%1.9%0.9 $6.16 4/30/202173,400 shares $616,560.00 +15.2%2.1%0.8 $8.40 4/15/202163,700 shares $596,232.00 +17.7%1.5%0.8 $9.36 3/31/202154,100 shares $590,231.00 +21.0%1.5%0.7 $10.91 3/15/202144,700 shares $518,520.00 +329.8%1.3%0.7 $11.60⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 2/26/202110,400 shares $110,968.00 -14.1%0.3%0.2 $10.67 2/12/202112,100 shares $95,590.00 +157.5%0.3%0.2 $7.90 1/29/20214,700 shares $29,187.00 -44.1%0.1%0.1 $6.21 1/15/20218,400 shares $57,456.00 No Change0.2%0.3 $6.84 9/30/2020100 shares $900.00 No ChangeN/A0 $9.00 PCSA Short Interest - Frequently Asked Questions What is Processa Pharmaceuticals' current short interest? Short interest is the volume of Processa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 71,600 shares of PCSA short. 2.47% of Processa Pharmaceuticals' shares are currently sold short. Learn More on Processa Pharmaceuticals' current short interest. What is a good short interest percentage for Processa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.47% of Processa Pharmaceuticals' floating shares are currently sold short. Is Processa Pharmaceuticals' short interest increasing or decreasing? Processa Pharmaceuticals saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 71,600 shares, a decrease of 2.1% from the previous total of 73,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Processa Pharmaceuticals' float size? Processa Pharmaceuticals currently has issued a total of 3,267,000 shares. Some of Processa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Processa Pharmaceuticals currently has a public float of 2,900,000 shares. How does Processa Pharmaceuticals' short interest compare to its competitors? 2.47% of Processa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Processa Pharmaceuticals: HCW Biologics Inc. (0.65%), TherapeuticsMD, Inc. (0.19%), Marinus Pharmaceuticals, Inc. (7.94%), PharmaCyte Biotech, Inc. (0.75%), Sol-Gel Technologies Ltd. (0.70%), ANEW Medical, Inc. (1.67%), Aspira Women's Health Inc. (4.33%), Imunon, Inc. (5.36%), ImmunoPrecise Antibodies Ltd. (1.30%), CervoMed Inc. (35.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Processa Pharmaceuticals stock? Short selling PCSA is an investing strategy that aims to generate trading profit from Processa Pharmaceuticals as its price is falling. PCSA shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Processa Pharmaceuticals? A short squeeze for Processa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PCSA, which in turn drives the price of the stock up even further. How often is Processa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCSA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies HCWB Short Squeeze TXMD Short Squeeze MRNS Short Squeeze PMCB Short Squeeze SLGL Short Squeeze WENA Short Squeeze AWH Short Squeeze IMNN Short Squeeze IPA Short Squeeze CRVO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCSA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCSA Stock Alerts